Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
From STT :
“I've been questioning 'rthm's bullish comments but then failing to back them up when it comes to results' or years...
anyone can read my posts... so the current situation is as expected.. “
----------------------------------------------------------------------------------------------------------------------------------------------------
But stt there has been many other posters who also questioned R1 and still do. Nothing wraong in that.
However, their stance and questioning has ONE BIG difference with YOUR past and present comments! AGENDA and MOTIVATION behind the posts.
It’s your Agenda/Motivation and relentless one sidedness that people have a problem with.
Eddie
Eddie,
"But stt there has been many other posters who also questioned R1 and still do."
Please feel free to name these 'MANY' other posters who have been CONSISTENT in questioning rthm, pre-TAP merger, and still do, post TAP merger...
"It’s your Agenda/Motivation and relentless one sidedness that people have a problem with."
How do you know what other posters think or are you trying to plant a view in poster's minds? Can you tell me what my agenda/motivation is as all all I've done is post company/industry stats/newsflow and formed an opinion based on them?
Currently, my investment decision has been proven right so conclusively by events, hasn't it?.
What's stopping you or anyone else sticking to TAP/industry stats/newsflow, posting about TAP and discussing TAP without the personal attacks? What's your agenda/motivation?
So please stick to posting about TAP or the Industry. I'm sure other posters would very much welcome that.
'Currently, my investment decision has been proven right so conclusively by events, hasn't it?'
As fictional as the films shown at the Cannes film festival. The events that have depressed the price recently have not been caused by industry reasons which you perpetuate (endlessly) but by unique isolated unforeseen events. Hagai selling off (fyi he sold a large chunk just before Taptica grew to over 400p so hardly an indicator), the Uber complaint...what of these have you predicted? R1 revenues...possibly... but we hardly have any clarity there. I agree with you, especially in hindsight, that R1 management were poor; I mention hindsight because I look at it relative to the Taptica management (which I questioned for a period given the vague RNSs but have since been reassured by the clear responses at the AGM).